Kymera Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Kymera Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
  • Kymera Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -229 %, a 42.1% increase year-over-year.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2023 was -211 %, a 38.8% increase from 2022.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2022 was -344 %, a 149% decline from 2021.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2021 was -138 %, a 1.46% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -229 +166 +42.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -210 +124 +37.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -224 +139 +38.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -211 +134 +38.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -395 -53.8 -15.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -333 -86 -34.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -364 -169 -86.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -344 -206 -149% Oct 1, 2022 Dec 31, 2022
Q3 2022 -341 -228 -202% Jul 1, 2022 Sep 30, 2022
Q2 2022 -247 -156 -172% Apr 1, 2022 Jun 30, 2022
Q1 2022 -195 -97.2 -99.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -138 -1.98 -1.46% Oct 1, 2021 Dec 31, 2021
Q3 2021 -113 Jul 1, 2021 Sep 30, 2021
Q2 2021 -91.1 Apr 1, 2021 Jun 30, 2021
Q1 2021 -97.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 -136 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.